Armin Rabsteyn

6PUBLICATIONS
28CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Sensor technology (incl. chemical aspects)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Case Report: A Multi-Peptide Vaccine Targeting Individual Somatic Mutations Induces Tumor Infiltration of Neoantigen-Specific T Cells in a Patient with Metastatic Colorectal Cancer.

Armin Rabsteyn, Henning Zelba, Borong Shao

|Jun 06, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.

|Dec 03, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.

Maximilian Stich, Vladimir Gonçalves Magalhães, Friederike Bürger

|Apr 27, 2024
Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.

Henning Zelba, Christina Kyzirakos, Simone Kayser

|Jan 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.

Claus-Philipp Maier, Chihab Klose, Christian Martin Seitz

|Nov 11, 2022
Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination-A Retrospective Observation.

Henning Zelba, Alex McQueeney, Armin Rabsteyn

Pageof 1

Frequent Collaborators

3 joint publications

Florian Battke

2 joint publications

Dirk Hadaschik

1 joint publications

Christian Martin Seitz

1 joint publications

Roland Meisel